FOI 7131 - Iron therapy in anaemia drugs used and patient numbers

Date: 02 March 2022 to 02 March 2025

I am researching the use of iron therapy in anaemia, in particular to understand the medical conditions and surgical procedures for which iron treatments are being used. I would greatly appreciate it if you could answer the following 3 questions:

 

Q1. How many patients have been treated in the last 6 months (for any disease) with the following products:

  • Feraccru (ferric maltol capsules)
  • Ferinject (ferric carboxymaltose injection/infusion)
  • Monofer (ferric derisomaltose injection)
  • Cosmofer (iron dextran injection)
  • Venofer (iron sucrose injection)
  • Any of the above 5 products

 

  •  

Q2. For the patients treated in the last 6 months with any of products listed in Q1, how many patients were diagnosed (at any point in the last 12 months) with the following:

  • Chronic Kidney Disease (ICD10 code – N.18)  
  • Heart Failure (ICD10 code – I.50)
  • Inflammatory Bowel Disease (ICD10 codes – K.50 to K.52)
  • Malignant neoplasms (ICD10 codes C.00 to c.96)
  • Post-Partum Haemorrhage (ICD10 code O.72)

 

 

Q3. For the patients treated in the last 6 months with any of products listed in Q1, how many patients undertook the following elective surgeries at any point in the last 12 months: 

  • Primary Hip Replacement (OPCS codes W371, W381 and W941)
  • Hysterectomy (OPCS codes Q074 and Q075)
  • Colorectal Resection (OPCS codes H071, H0712, H073, H074, H333 and H336)
  • Coronary Artery Bypass Graft (OPCS code K453)
  • Cardiac Valve Surgery (OPCS codes K262 and K255)
  • Request ID:
    7131
  • Category:
    Clinical - Drugs
  • Response:

    March 2022

    Freedom of Information Request: reference 7131

    Thank you for your recent request under the Freedom of Information Act 2000.

    The information you have requested is as follows:

     

    Q1. How many patients have been treated in the last 6 months (for any disease) with the following products:

    • Feraccru (ferric maltol capsules)
    • Ferinject (ferric carboxymaltose injection/infusion)
    • Monofer (ferric derisomaltose injection)
    • Cosmofer (iron dextran injection)
    • Venofer (iron sucrose injection)
    • Any of the above 5 products

     

     

    Please see below data held by the Trust’s Pharmacy department. If the drug is not listed it is because it has not been issued in the past 6 months.

     

    Issue to patients

     

    Drug Name, Strength and Form.

    Number of Patients

    FERRIC CARBOXYMALTOSE 1000 mg in 20ml Injection

    785

     

    Issue to ward – no patient details available.

     

    Drug Name, Strength and Form

    Sum of Net Qty in dose units

    IRON ISOMALTOSIDE (DIAFER) (ferric derisomaltose) 100 mg in 2ml Solution for Injection

    1225

     

     

    Q2. For the patients treated in the last 6 months with any of products listed in Q1, how many patients were diagnosed (at any point in the last 12 months) with the following:

    • Chronic Kidney Disease (ICD10 code – N.18)
    • Heart Failure (ICD10 code – I.50)
    • Inflammatory Bowel Disease (ICD10 codes – K.50 to K.52)
    • Malignant neoplasms (ICD10 codes C.00 to c.96)
    • Post-Partum Haemorrhage (ICD10 code O.72)

     

     

    The Trust regret we are unable to answer this question as data relating to which patients were treated with which products is not collated by the Trust. The Trust’s Pharmacy department can advise products issued from their department, but they do not record the indication for its use.

    The Trust’s BI department can advise numbers of patients admitted with the above conditions, however, the patient’s treatment is not recorded alongside this data, nor is the date of initial diagnosis. Please see below patient admission data for information.

    Diagnosis

    Number of Patients

    Chronic Kidney Disease

    2379

    Heart Failure

    2471

    Inflammatory Bowel Disease

    1466

    Malignant neoplasms

    6899

    Post-Partum Haemorrhage

    1439

    Grand Total

    14654

     

    Q3. For the patients treated in the last 6 months with any of products listed in Q1, how many patients undertook the following elective surgeries at any point in the last 12 months:

    • Primary Hip Replacement (OPCS codes W371, W381 and W941)
    • Hysterectomy (OPCS codes Q074 and Q075)
    • Colorectal Resection (OPCS codes H071, H0712, H073, H074, H333 and H336)
    • Coronary Artery Bypass Graft (OPCS code K453)
    • Cardiac Valve Surgery (OPCS codes K262 and K255)

     

     

    As above, we regret this data is not collated by the Trust. Please see below the number of procedures undertaken in the last 12 months, but we cannot confirm whether or not they were being treated with the products listed in question 1.

     

    Procedure

    Number of Patients

    Colorectal Resection

    68

    Hysterectomy

    146

    Coronary Artery Bypass Graft

    0

    Primary Hip Replacement

    176

    Grand Total

    390